English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Correction to: Molecular Psychiatry (2004) 9, 1060–1061. doi:10.1038/sj.mp.4001561 Following the publication of the above paper, the author has identified errors in Figure 1. The correct Figure 1 is shown below. The synonymous mutation gene C957T in the human D2 dopamine receptor (DRD2) significantly affects striatal DRD2 availability in vivo. The data should indicate that the C957T polymorphism had a highly significant effect on DRD2 binding potential (BP) with highest BP in T/T, intermediate in C/T and lowest in C/C genotype. The result is not in line with the previous in vitro study (Duan J et al. Hum Mol Genet 2003; 12: 205–216) in which the T allele of the C957T polymorphism was associated with reduced mRNA stability and synthesis of the dopamine D2 receptor.

Erratum: C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo